Blood cancers, Myelodysplastic syndrome (MDS)
Results
Phase 2
This study looked at deferasirox to reduce iron levels in the body before they get too high.
Recruitment start: 25 January 2013
Recruitment end: 30 November 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Dominic Culligan
NIHR Clinical Research Network: Cancer
University of Birmingham
Novartis
Bloodwise
Last reviewed: 12 February 2020
CRUK internal database number: 8094
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
